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Cell deathrring compound from peppermint oil, binds and activates the TRPM8 Ca2+-
permeable channel that exhibits abnormal expression patterns in prostate cancer, suggesting that TRPM8
links Ca2+ transport pathways to tumor biology. We thus investigated the cellular responses of prostate
cancer cells to menthol. Here we found that menthol increases [Ca2+]i via Ca2+ inﬂux mechanism(s)
independent of TRPM8 in PC-3 cells. We demonstrated that menthol induces cell death at supramillimolar
concentrations in PC-3 cells and the cell death is not suppressed by low extracellular Ca2+ condition which
indicates that menthol-induced cell death is not associated with Ca2+ inﬂux pathways. In addition, we
showed that menthol increases a phosphorylated form of c-jun N-terminal kinase (JNK) in PC-3 cells through
TRPM8-independent mechanisms. Thus, our data indicate that there is an apparent lack of causality between
TRPM8 activation and menthol-induced cell death and that menthol can regulate TRPM8-independent Ca2+-
transport and cellular processes.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Prostate cancers initially respond very well to androgen-depriva-
tion therapy. Nonetheless, they eventually evolve into recurrent
androgen-independent cancers for which no effective therapy is
available [1]. Therefore, uncovering distinct molecular pathways
involved in the progression of hormone-refractory prostate cancer is
imperative for developing better therapeutic strategies. Ca2+ controls
twomutually exclusive cellular processes: proliferation and cell death.
It has been implicated that deregulated Ca2 transport has possible
roles in tumorigenesis and tumor progression [2]. Thus, Ca2+ transport
has emerged as a novel therapeutic target for cancers [2]. Transient
receptor potential melastatin 8 (TRPM8), a Ca2+-permeable cation
channel, is known to regulate [Ca2+]i in response to cold temperature
or pharmacologic stimuli [3]. It was initially identiﬁed as an up-
regulated gene in prostate cancer [4]. TRPM8 expression was found to
increase in androgen-dependent cancer and subsequently decrease as
it progressed into a hormone-refractory cancer [5]. Thus, aberrant
expression of TRPM8 may link disturbed cellular Ca2+ transports to
tumor biology. However, little is known about a pathophysiological
role of TRPM8 in prostate cancer.
Menthol, a naturally occurringmonocyclic terpene alcohol, is a key
component of peppermint oil, which has been widely used in
cosmetics, pharmaceutical products, and as ﬂavoring in food [6]. It iselastatin 8; I–V curve, current
2 2 763 9667.
l rights reserved.considered to be Generally-Recognized-As-Safe and has been
approved for over-the-counter external use in concentrations up to
16% [6]. It was through the process inwhich TRPM8was identiﬁed as a
molecular target of menthol that the underlying mechanisms by
which menthol elicits a cool sensation have been unraveled [7,8]. In
addition, recent reports postulated that menthol has antitumor
activity and chemopreventive potential [9,10] that was ascribed to
TRPM8 activation and its resultant [Ca2+]i increase [9]. However,
recent studies revealed that menthol response is also mediated by
non-TRPM8 pathways, such as TRPM8-independent Ca2+ release [11]
or TRPA1 activation [12]. Therefore, it is uncertain whether TRPM8
activation underlies menthol-induced [Ca2+]i increase in prostate
cancer cells. Moreover, it is questionable whether the menthol-
induced Ca2+ transport can modulate cell viability. Thus, we have
questioned whether menthol affects cell viability through TRPM8-
dependent Ca2+ pathways. In this study, we investigated cellular
responses to menthol in cultured cell system using androgen-
dependent LNCaP and androgen-independent PC-3 prostate cancer
cells. We will present evidence that menthol elicits cell death through
TRPM8-independent Ca2+ transport and cellular processes.
2. Materials and methods
2.1. Cell viability assay
LNCaP and PC-3 cells were supplied by Korean Cell Line Bank
(KCLB). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT)
or LDH release assay was used to assess cell viability according to
the manufacturers' instructions (Sigma or Promega, respectively).
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Assays were quantitated by measuring the absorbance at 570 nm on
microplate spectrophotometer (ASYS). All cell culture agents used
were obtained from Invitrogen.
2.2. Flow cytometry analysis
The cells ﬁxed with 70% ethanol were labeled with propidium
iodide (50 μg/ml, Sigma) solution containing RNase A (100 μg/ml).
Subsequently, the cells were analyzed by ﬂow cytometry (BD
Biosciences). ModFitLT V3.0 software was used for data analysis.
2.3. RT-PCR analysis
Total RNA was extracted from LNCaP and PC-3 cells using TRIzol
reagent (Invitrogen). Reverse transcription was performed using a
commercial kit according to the manufacturer's instruction (Invitro-
gen). PCR was performed as described in Supplementary Fig. 1.
2.4. Intracellular Ca2+ measurement
The detached cells were loaded with 5 μM Fura-2 acetoxymethyl
ester (Molecular probes) in serum-free RPMI for 30 min at room
temperature. The cells were washed twice and resuspended with
normal Tyrode's solution containing 3.6 mM KCl, 1 mMMgCl2, 145 mM
NaCl, 1.3 mM CaCl2, 5 mM glucose, and 10 mM HEPES. For Ca2+ free
normal Tyrode's solution, 2 mM EGTA was included instead of CaCl2.
Fluorescence emission at 510 nmwas measured with excitation at 340/
380 nm in a stirred quartz-microcuvette (1 ml) of ﬂuorescence
spectrophotometer (Photon Technology Instrument, NJ). Maximum
and minimum ﬂuorescence values were calibrated by addition of 0.2%
Triton X-100 and 10 mM EGTA. The [Ca2+]i was calculated from the
equation, [Ca2+]=Kd×b×(R−Rmin)/(Rmax−R) where Kd is the dissocia-
tion constant for Fura-2, b is the ratio of ﬂuorescence excitation
intensity at 380 nmunder Ca2+-free and Ca2+-saturated condition, and R
is F340/F380. Kd of Fura-2 was additionally corrected for the different
temperature as described previously [13].
2.5. Electrophysiology
Patch clamp experiments were performed in the whole-cell
conﬁguration using an Axopatch I-D ampliﬁer. Electrode resistance
was between 2 and 5 MΩ and 60% of the series resistance was
compensated. The internal (pipette) solution was composed of
140 mM CsCl, 10 mM HEPES, and 0.5 mM EGTA, buffered at pH 7.2
with CsOH. The extracellular solution consisted of 150mMNaCl, 5 mM
MgCl2, 1 mM EGTA, and 10 mM HEPES, buffered at pH 7.4 with NaOH.
Stimulation of TRPM8 currents was achieved by application of 1 mM
(−)-menthol (Sigma) to the bath solution. Current–voltage relation-
ship was obtained by linear 400 ms voltage ramps from −100 to
+100 mV at a holding potential of −60 mV.
2.6. Western blot analysis
The total proteins were prepared by incubation with RIPA buffer
with protease inhibitor and phosphatase inhibitor cocktail. The
proteins were resolved in 12% SDS-PAGE and analyzed with antibodies
speciﬁc for Caspase-3, ERK, pERK, p38, pp38, JNK, and pJNK (cell
signaling).
3. Results
3.1. Menthol elicits TRPM8-independent Ca2+ transport
In order to assure the speciﬁcity of cellular responses to menthol,
we ﬁrst analyzed the expression of TRPM8 and TRPA1, which areestablishedmolecular targets for menthol. As shown in nested RT-PCR
analysis, TRPM8 expression was evident in both LNCaP and PC-3 cells.
Contrastingly, TRPA1 was not detected (Fig. 1A), which was validated
by nested RT-PCR experiments using the samples from human TRPA1-
transfected HEK 293 cells (Supplementary Fig. 1). These results
suggest that TRPA1 does not mediate menthol responses in both cell
lines. We then measured menthol reactivity in terms of the change in
[Ca2+]i. When [Ca2+]i was measured using Fura-2, there was consider-
able differences between the cell lines with respect to menthol
response patterns: a slow and continuous dose-related increase in
LNCaP cells (Fig. 1B), whereas an immediate robust dose-related but
transient increase in PC-3 cells (Fig. 1C). Peak increase in [Ca2+]i
induced by 1 mM of menthol was 42.3±9 nM (n=3) in LNCaP and
224.5±83 nM (n=4) in PC-3 cells.
Because little has been known about menthol response in PC-3
cells, in contrast to that in LNCaP cells [9,14], we further examined
whether menthol response is mediated by TRPM8 in PC-3 cells.
Menthol evoked amore obvious increase in [Ca2+]i at 37 °C rather than
25 °C (Fig.1D), opposite to the property of TRPM8 [3]. In thewhole-cell
patch clamp study with PC-3 cells (Fig. 1E), the I–V curve (current to
voltage relation curve) in the cells exposed to menthol was
inconsistent with that of menthol-activated TRPM8 whose hallmark
is an outwardly rectifying I–V curve [11]. In addition, we did not
observe typical TRPM8 current that is characterized by fast activation
by menthol application and fast deactivation upon its removal
(Supplementary Fig. 2). These results indicate that menthol response
is mediated by non-TRPM8 and non-TRPA1 pathway in PC-3 cells.
To get an insight into the novel actions of menthol, we examined
whether menthol-induced [Ca2+]i increase resulted from Ca2+ inﬂux
across the plasma membrane or Ca2+ release from intracellular stores
in PC-3 cells. Under extracellular Ca2+-free conditions, menthol failed
to increase [Ca2+]i in PC-3 cells (Fig.1F). By contrast, mentholmarkedly
increased [Ca2+]i in the presence of Ca2+ at 2mM (Fig.1F). These results
suggest that menthol increases [Ca2+]i mainly through the activation
of Ca2+inﬂux pathway(s).
3.2. Menthol induces TRPM8-independent cell death
Menthol was reported to be effective in treating prostate cancer in
vitro possibly due to TRPM8 activation and its resulting increase in
[Ca2+]i [9]. However, our data, as well as those of others, indicate that
TRPM8-independent mechanisms are involved in menthol-induced
increase in [Ca2+]i (Fig. 1 and ref. [11)]. Moreover, a rise in [Ca2+]i can
induce either cell proliferation or death, depending on cell types and
spatiotemporal patterns of [Ca2+]i [2,15]. We thus questioned the
phenotypical consequence of the PC-3 cells treated with menthol.
MTT assays showed that viable cell population gradually decreased in
relation to menthol concentrations (Fig. 2A). Supramillimolar con-
centrations of menthol accelerate cell death (Fig. 2A), and most cells
died at 72 h upon menthol above 2.5 mM (Fig. 2A and B). The growth
inhibition by menthol at 1 mM resulted from mild cytotoxic effects
(Fig. 2B), which was veriﬁed by LDH release assays (Fig. 2D), but not
from growth arrest (Fig. 2C). Each phase of the cell cycle in PC-3 cells
was unaffected by menthol at 1 mM. Cell cycle in LNCaP cells was also
unaffected by menthol at 1 mM (Supplementary Fig. 3). However, LDH
release assay showed that LNCaP cells are more resistant to menthol
toxicity than PC-3 cells (Fig. 2D). Menthol at 2.5 mM showed
amorphous cell cycle proﬁles due to massive cell death. Because
EC50 values for menthol-mediated TRPM8 activation were previously
reported to be 4–100 μM depending on analytical methods and assay
temperature [11,16], our ﬁndings indicate that menthol induces cell
death by mechanisms independent of TRPM8 activation in PC-3 cells.
We then examined the causal relationship between menthol-
induced Ca2+ inﬂux and cell death. In PC-3 cells, lowering extracellular
Ca2+ concentration (Ca2+-free mediumwith 10% FBS) did not suppress
cell death induced by menthol at 2.5 mM, but rather enhanced cell
Fig. 1. Intracellular Ca2+ change in response to menthol in LNCaP and PC-3 cells. (A) The expression of TRPM8 and TRPA1was detected by nested RT-PCR. The [Ca2+]i was measured using
Fura-2 in LNCaP cells (B) and in PC-3 cells (C). (D) Dose-response curves at 25 and 37 °C in PC-3 cells. The ﬁgure (mean±S.D) shows the difference in peak [Ca2+]i increase. (n=3–5). (E) I–V
relationship obtainedbywhole-cell patch clampanalysis in 1mMmenthol-treatedPC-3 cells using CsCl pipette solution andNTbath solution 25 °C. (F)Menthol-induced [Ca2+]i increase in
the absence orpresenceof extracellular Ca2+ inPC-3 cells.Data shownare representative result of at least three independent experiments. Theexperiments shown inpanels B, C, and Fwere
performed at 37 °C and those shown in panel E were done at 25 °C.
35S.-H. Kim et al. / Biochimica et Biophysica Acta 1792 (2009) 33–38death (Fig. 2E). In LNCaP cells, menthol-induced comparable cell
death, irrespective of extracellular Ca2+(Supplementary Fig. 4). These
results suggest a lack of causality between menthol-induced Ca2+
inﬂux and cell death in prostate cancer cells. Particularly, cell death
was more notable in PC-3 cells than that in LNCaP cells (Fig. 2F).
Furthermore, HEK 293 cells, in which TRPM8 is not detected [11], was
the most sensitive to menthol-induced cell death among the cell lines
examined (Fig. 2F). These results indicate that TRPM8 expression does
not correlate with menthol-induced cell death, which conﬁrm a lack
of causality between TRPM8 activation and menthol-induced cell
death.
3.3. Menthol regulates TRPM8-independent signaling pathways
To understand the mechanisms of action of menthol, we
investigated whether menthol can activate caspase cascades in PC-3cells. All caspase inhibitors used did not block cell death (Fig. 3A).
These results were veriﬁed by Western blot analyses, which showed
no cleaved bands of caspase-3 irrespective of the presence of Ca2+ (Fig.
3B) which indicates that supramillimolar concentrations of menthol
triggers caspase pathway-independent cell death in PC-3 cells.
However, PC-3 cells were more susceptible to cell death than LNCaP
cells at comparable concentrations of menthol (Fig. 2F) which
suggests that PC-3 cells may have certain mechanisms vulnerable to
menthol-induced cell death.
Because mitogen-activated protein (MAP) kinases play important
roles in stress-induced cell death [17], we examined whether menthol
acts as a cellular stress to activate MAP kinases in PC-3 cells. Western
blot analyses showed that menthol does not elevate a phosphorylated
form of ERK and p38 kinases (Fig. 3C). By contrast, a phosphorylated
formof JNKwas observed at the 1 hmark after treatmentwithmenthol
but was no longer present in subsequent observations (Fig. 3C) which
Fig. 2. Cytotoxic effect of menthol in LNCaP and PC-3 cells. The cells were grown in the culture medium containing 1.8 mM CaCl2 and 10% FBS except panel E. (A) Dose-response effect
of menthol. PC-3 cells were culturedwithmenthol for 72 h prior toMTTassays. Cell viability is expressed as a relative value to an absorbance value of the vehicle-treated cells which is
set to 100%. (B) Time-dependent effect of menthol on PC-3 cells. Cell viability is expressed as a relative value to that of the cells treated with vehicle and harvested at zero time which
is set to 100%. (C) PC-3 cells were incubatedwithmenthol for 72 h prior to ﬂow cytometric analysis. (D) LNCaP and PC-3 cells were culturedwithmenthol for 72 h prior to LDH release
assay. LDH release is expressed as a relative value to that of vehicle-treated cells which is set to 100%. (E) The effect of extracellular Ca2+ on cell growth in PC-3 cells. Extracellular [Ca2+]
was adjusted by addition of CaCl2 solution to Ca2+-free DMEM. The Ca2+ included in 10% FBS was not removed in our experiments. The cells were treated with menthol in each culture
medium for 48 h. (F) Differential effect ofmenthol on cell growth among LNCaP, PC-3, andHEK 293 cells. The cell lineswere culturedwithmenthol for 72 h. Theﬁgures showmean±S.D
(n=3–5).
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We then examined MAP kinase activity in LNCaP cells. Comparable to
the results fromPC-3 cells, neither ERKnor p38 kinasewas activated by
menthol in LNCaP cells. Although JNK was activated by menthol, its
activation pattern in LNCaP cells was different from that in PC-3 cells.
JNK activationwas observed following treatmentwithmenthol for 2 h,
and was sustained thereafter in LNCaP cells (Fig. 3D). We theninvestigated the role of Ca2+ in mediation of menthol-induced JNK
activation. In PC-3 cells, low extracellular Ca2+ did not suppress but
rather potentiated JNK activation (Fig. 3E), which indicates that
menthol-induced Ca2+ inﬂux is not causally related to JNK activation,
correlating with a phenomenon observed in menthol-induced cell
death (Fig. 2E). By contrast, in LNCaP cells, extracellular Ca2+
concentration did not affect menthol-mediated JNK activation
Fig. 3.Modulation of caspase andMAP kinase pathways bymenthol in LNCaP and PC-3 cells. (A) The effect of caspase inhibitors on viability in PC-3 cells. The cells were exposed to the
culture medium containing 1.8 mM CaCl2 and 2.5 mMmenthol in the absence or presence of caspase inhibitors and cultured for 72 h prior to MTT assays. Cell viability is expressed as
a relative value to an absorbance value of vehicle-treated cells which is set to 100%. The ﬁgures showmean±S.D (n=3). (B)Western blot analyses of proteins following treatment with
menthol at 2.5 mM in PC-3 cell. The cells were cultured in the absence or presence of extracellular Ca2+ for 48 h or the indicated times. (C–D)MAP kinase signaling inmenthol-treated
PC-3 (C) and LNCaP cells (D). Western blot analyses of proteins following treatment with menthol at 2.5 mM in both cell lines. The cells were cultured in the culture medium
containing CaCl2 at 1.8 mM andmenthol at 2.5 mM for the indicated times. (E–F) The effect of extacellular Ca2+ onmenthol-induced JNK activation in PC-3 (E) and LNCaP (F). Western
blot analyses of proteins following treatment with menthol at 2.5 mM in both cell lines. The cells were cultured in the absence or presence of extracellular Ca2+ for 1 h (PC-3) or 2 h
(LNCaP). Western blotting data shown are representative results of four to six independent experiments.
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Supplementary Fig. 4, suggesting that JNK activation may be involved
in menthol-induced cell death. In addition, our ﬁndings indicate that
TRPM8 is not involved in menthol-induced JNK activation.
4. Discussion
In this study we described three main ﬁndings: 1) a novel TRPM8-
and TRPA1-independent pathway mediates menthol-induced Ca2+
transport in PC-3 cells; 2) menthol elicits cell death by mechanisms
independent of TRPM8 and Ca2+ transport; 3) menthol activates JNK
via Ca2+-independent pathway(s). Thus, our ﬁndings indicate that
menthol plays a role in TRPM8-independent Ca2+-transport and
cellular processes.
Because TRPM8 expression in PC-3 cells has been disputed [14,18]
and the speciﬁcity of commercially available antibodies to TRPM8 isunreliable [11], we veriﬁed its expression by nested RT-PCR method
(Fig. 1A). However, as presented in Fig. 1, neither cold-activated [Ca2+]i
increase nor menthol-reactive TRPM8-like current (outwardly rectify-
ing curve) was observed. Furthermore, menthol-induced [Ca2+]i
increase was not potentiated by cold conditions. Thus, our data
indicate the presence of novel, unidentiﬁed mechanisms in menthol-
induced [Ca2+]i increase. The reason for TRPM8's apparent inactivity,
despite its expression in PC-3 cells, can be explained in three possible
ways: 1) functional TRPM8 expression is too low to be detected by the
current assay methods, 2) TRPM8 is inactivated by loss-of-function
mutation, or 3) unrecognized cellular factor(s) interfere with TRPM8
activation.
TRPM8 up-regulation is associated with the early stages of prostate
cancer. By contrast, TRPM8 loss strongly correlateswith poor prognosis
of patients with advanced prostate cancer [5]. This conﬂicting
molecular proﬁle complicates the understanding of the role of
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TRPM8 is active in prostate cancer environments. Prostate cancer is
closely associated with chronic inﬂammation, such as proliferative
inﬂammatory atrophy [19], which can affect TRPM8 activity negatively
due to PIP2 depletion and PKC activation [3,20]. In addition, PTEN
mutation is often observed in prostate cancer, which can ameliorate
the conversion of PIP3 back to PIP2 [21]. Furthermore, cold activation of
TRPM8 outside the sensory tissue is unlikely to occur, and endogenous
ligands have been unidentiﬁed. However, the pathophysiological role
of TRPM8 in prostate carcinogenesis still remains to be elucidated.
Prolonged TRPM8 activation by menthol treatment and the
resulting perturbation of Ca2+ homeostasis has been postulated to
trigger cell death [9]. However, we demonstrated that both prostate
cancer cell lines die in the presence of menthol at supramillimolar
concentrations (particularly, LNCaP cells are remarkably resistant to
cell death), which is at least 10-fold higher than EC50 values for TRPM8
activation [11,16] which suggests a lack of association between TRPM8
activation and cell death. Moreover, we did not ﬁnd a causal relation
betweenmenthol-induced Ca2+ transport and cell death. Furthermore,
we found that JNK activation is not causally related to menthol-
induced Ca2+ inﬂux (Fig. 3E and F). Therefore, our ﬁndings suggest that
the phenotypical consequences of menthol treatment are required to
distinguish TRPM8-dependent processes from TRPM8-independent
ones. Unfortunately, we provided little information concerning
mechanisms underlying cell death. However, it is of interest that
menthol acts differentially on prostate cancer cells in terms of Ca2+
response, sensitivity to cell death, and JNK activation patterns (Fig. 1B,
C and 2 F). These results suggest that menthol may be used as a
valuable probe to discover the functional differences between
androgen-dependent and androgen-independent prostate cancers
and thereby provide helpful clues to therapeutic strategy
development.
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